BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15573856)

  • 1. Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy.
    Khan MQ; Al Kahtani KM; Al-Ashgar H
    Ann Saudi Med; 2004; 24(5):386-90. PubMed ID: 15573856
    [No Abstract]   [Full Text] [Related]  

  • 2. Ectopic Cushing syndrome: Report of 9 cases.
    Araujo Castro M; Palacios García N; Aller Pardo J; Izquierdo Alvarez C; Armengod Grao L; Estrada García J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 May; 65(5):255-264. PubMed ID: 29655957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative therapy of an ectopic Cushing's syndrome due to a metastatic carcinoid tumor.
    Kornely E; Schlaghecke R; Horster FA
    Klin Wochenschr; 1991 Feb; 69(4):173-6. PubMed ID: 1710306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Ectopic ACTH secretion due to a metastatic atypical lung carcinoid tumor. From diagnosis to treatment.
    Hoornaert E; Jacqmin L; Montfort L; Maiter D; Derdelinckx L
    Ann Endocrinol (Paris); 2019 Apr; 80(2):137-139. PubMed ID: 30739712
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary hepatic carcinoid tumor presenting as Cushing's syndrome.
    Shah NA; Urusova IA; D'Agnolo A; Colquhoun SD; Rosenbloom BE; Vener SL; Geller SA; Younes M; Lechago J; Heaney AP
    J Endocrinol Invest; 2007 Apr; 30(4):327-33. PubMed ID: 17556871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic carcinoid tumours with octreotide.
    Ozbey N
    Int J Clin Pract; 2002 Jun; 56(5):407. PubMed ID: 12137455
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of a patient on long-term follow-up.
    Tohyama T; Matsui K; Kitagawa K
    Intern Med; 2005 Sep; 44(9):958-62. PubMed ID: 16258211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic ACTH-syndrome due to a thymic carcinoid tumor.
    Van Schaeybroeck S; Van Imschoot S; Cochez P
    Acta Clin Belg; 2002; 57(1):23-5. PubMed ID: 12017752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoid-associated ectopic ACTH syndrome with variable response to octreotide.
    Gill GV; Yong A; Power E; Ramage J
    Postgrad Med J; 1999 Feb; 75(880):98-100. PubMed ID: 10448471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoid tumor regression with high-dose octreotide acetate: a patient report.
    Lokich J
    Am J Clin Oncol; 1998 Jun; 21(3):246-7. PubMed ID: 9626790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent hypokalemia after successful adrenalectomy in a patient with Cushing's syndrome due to ectopic ACTH secretion: possible role of 11beta-hydroxysteroid dehydrogenase inhibition.
    Arteaga E; Fardella C; Campusano C; Cárdenas I; Martinez P
    J Endocrinol Invest; 1999 Dec; 22(11):857-9. PubMed ID: 10710274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic ACTH syndrome due to thymic atypical carcinoid treated with combination chemotherapy of cisplatin and etoposide.
    Takahashi T; Hatao K; Yamashita Y; Tanizawa Y
    Intern Med; 2003 Dec; 42(12):1197-201. PubMed ID: 14714958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
    Norton JA; Kerlan RK
    Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor.
    Christin-Maitre S; Chabbert-Buffet N; Mure A; Boukhris R; Bouchard P
    Chest; 1996 Mar; 109(3):845-6. PubMed ID: 8617102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide.
    Van den Bruel A; Bex M; Van Dorpe J; Heyns W; Bouillon R
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):541-6. PubMed ID: 9876354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
    Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
    Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.
    Siu LL; Chapman W; Moore MJ
    Am J Clin Oncol; 1997 Dec; 20(6):558-61. PubMed ID: 9391539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid tumour management in haemodialysis: a case report.
    Burke MT; Gray NA
    Nephrology (Carlton); 2012 Feb; 17(2):198. PubMed ID: 22257155
    [No Abstract]   [Full Text] [Related]  

  • 19. Octreotide and ketoconazole for persistent ectopic ACTH Cushing's disease due to mediastinal carcinoid.
    Parthiban A; Sundaram DS; Reddy DJ; Girinath MR; Prabhakaran R; Chidambaranathan N
    J Assoc Physicians India; 1995 Feb; 43(2):140. PubMed ID: 9282686
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
    Condron ME; Pommier SJ; Pommier RF
    Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.